Periconceptional maternal vitamin supplementation and childhood leukaemia: an uncertainty analysis.
BACKGROUND
Recent studies in childhood cancer suggest that maternal vitamin supplementation may reduce the risk of leukaemia, neuroblastoma and certain types of childhood brain tumours. For example, a previous study found a significantly reduced risk of acute lymphoblastic leukaemia (ALL) but not acute myeloid leukaemia (AML) in children with Down syndrome whose mothers reported any vitamin supplement use prior to knowledge of pregnancy (ALL OR adjusted for confounders 0.51, 95% confidence limits (CL): 0.30, 0.89; AML OR adjusted for confounders 0.92, 95% CL 0.48, 1.76). Recall of exposures, including maternal vitamin supplement use, however, may be difficult and subject to error. Epidemiologists are encouraged to quantitatively adjust for systematic error in study results, but often do not.


METHODS
The impact that misclassification of maternal vitamin supplement use may have had on the observed ORs in this study was quantified. Uncertainty analysis was used to calculate ORs adjusted for inaccurate reporting of vitamin supplement use under assumed probability distributions for exposure misclassification parameters.


RESULTS
Given our assumptions, adjustment for exposure misclassification yielded ORs that were predominantly more protective for ALL than the crude OR.


CONCLUSIONS
Uncertainty analysis can give important insights into the magnitude and direction of error in study results due to exposure misclassification.
Jurek
A M
AM
University of Minnesota, Department of Pediatrics, Mayo Mail Code 715, 420 Delaware St. SE, Minneapolis, MN 55455, USA. jure0007@umn.edu
Maldonado
G
G
Spector
L G
LG
Ross
J A
JA
D015982:Bias; D002648:Child; D019587:Dietary Supplements / Q000706:statistics & numerical data*; D004314:Down Syndrome / Q000150:complications / Q000453:epidemiology; D005260:Female; D006801:Humans; D011939:Mental Recall; D016742:Preconception Care / Q000379:methods* / Q000706:statistics & numerical data; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000196:embryology / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D035501:Uncertainty; D014815:Vitamins / Q000008:administration & dosage*
D014815:Vitamins